The Office of the United States Trade Representative (“USTR”) announced on September 6, 2023 the further extension of 352 reinstated exclusions and 77 COVID-related exclusions from the Section 301 tariffs on imports from China. These exclusions, which cover a variety of products ranging from machinery components to medical equipment, constitute the only remaining active exclusions
Section 301 Tariffs
Nearly 1500 Responses Submitted to USTR as Part of the Section 301 Four Year Review Process – Is Relief on the Way?
This Tuesday, January 17, marked the close for the Office of the United States Trade Representative’s (USTR’s) comment period for its statutory 4-year review of tariffs imposed on Chinese goods under Section 301 of the Trade Act of 1974. To-date, the Biden Administration has retained Section 301 tariffs on over $300 billion worth of imports…
USTR Announces 9-Month Extensions for 352 Exclusions
On December 16th, the United States Trade Representative (“USTR”) extended 352 exclusions which exclude certain products from the additional duties caused by the Section 301 actions taken against imports from China. These exclusions were scheduled to expire on December 31, 2022 but will now extend until September 30, 2023. USTR reinstated these 352…
USTR extends COVID-related Section 301 tariff exclusions for 81 medical care products
On Wednesday, November 23, the Office of the U.S. Trade Representative (USTR) extended exclusions from Section 301 tariffs for 81 medical care products from China for a sixth time. The tariff exclusions for these products were initially granted in December 2020 and had been extended multiple times throughout the COVID-19 pandemic. The tariff exclusions for…
USTR Releases Preview of Questionnaire for Four-Year Section 301 Tariff Review
On Tuesday (Nov. 1, 2022), the Office of the United States Trade Representative (“USTR”) released a preview of its questionnaire seeking comments on the effectiveness and impacts of the additional duties levied on Chinese-origin goods enacted under Section 301 of the Trade Act of 1974 (“Section 301 tariffs”). The Section 301 tariffs, which commenced in…
USTR Seeks Public Comments on the Effectiveness of Section 301 Tariffs on Chinese Goods
The Office of the U.S. Trade Representative (“USTR”) announced on Wednesday in a Federal Register notice that it is seeking public comments on the effectiveness of Section 301 tariffs on Chinese goods. The docket to post comments will open on November 15, 2022 and close on January 17, 2023. USTR welcomes any interested party to…
USTR Says China Section 301 Tariffs to Remain in Place
On September 2, 2022, the Office of the U.S. Trade Representative (USTR) announced that its statutory four-year review of Section 301 tariffs imposed on Chinese goods on July 6 and August 23, 2018 will be extended, with the tariffs remaining in effect while the agency conducts a more comprehensive review of their necessity. USTR stated…
USTR releases remand results on US-China Section 301 Tariffs
On Monday, August 1st, the Office of the U.S. Trade Representative (USTR) filed remand results with the U.S. Court of International Trade (CIT), releasing updated explanations for retaliatory tariffs on roughly $300 billion worth of Chinese goods imposed in the midst of the U.S. – China Trade War. USTR filed the remand as…
U.S. Court of International Trade Rules USTR Violated APA When Imposing Section 301 List 3 and List 4A Tariffs on Chinese Goods
On April 1, 2022, a three judge panel of the U.S. Court of International Trade (CIT) unanimously found that the Office of the United States Trade Representative’s (USTR’s) imposition of Section 301 List 3 and List 4A tariffs on Chinese products failed to comply with the Administrative Procedures Act (APA). Specifically, the court ruled that…
CIT issues Preliminary Injunction Temporarily Restraining Liquidation of Section 301 Import Entries
On August 24,2017, the Office of the U.S. Trade Representative (USTR) began a Section 301 investigation to determine whether acts, policies, and practices of the Government of China related to technology transfer, intellectual property, and innovation were actionable under the Trade Act of 1974. On March 22, 2018, USTR announced its affirmative findings and imposed…